The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus apatinib in patients with advanced or refractory chordoma: A single-arm, open-label, phase 2 trial.
 
Cheng Yang
No Relationships to Disclose
 
Qi Jia
No Relationships to Disclose
 
Chenglong Zhao
No Relationships to Disclose
 
Haifeng Wei
No Relationships to Disclose
 
Tielong Liu
No Relationships to Disclose
 
Xinghai Yang
No Relationships to Disclose
 
Jian Jiao
No Relationships to Disclose
 
Zhipeng Wu
No Relationships to Disclose
 
Jian Zhao
No Relationships to Disclose
 
Weiwei Zhou
No Relationships to Disclose
 
Xiaomei Ma
No Relationships to Disclose
 
Yan Lou
No Relationships to Disclose
 
E Zhang
No Relationships to Disclose
 
Jingyu Xing
No Relationships to Disclose
 
Hao Zhang
No Relationships to Disclose
 
Jianru Xiao
No Relationships to Disclose